Phoenix Life Sciences International Announces the Release of the Company's Investor Relations Deck and Accompanying Video Pre...
December 06 2018 - 9:56AM
InvestorsHub NewsWire
DENVER, CO -- December 06, 2018 --
InvestorsHub NewsWire -- Phoenix Life Sciences
International Limited (PLSI)
(“Phoenix Life”), an international adaptive healthcare solutions
company, today announced that it has released an online version of
its Investor Relations deck with an accompanying video presentation
on its website and at
http://phxlife.net/PLSI-Deck.
During the presentation video,
Phoenix Life CEO Martin Tindall walks prospective investors through
the company’s background, overall mission, business model, future
plans and information on how to invest in Phoenix Life’s goal of
transforming the future of global healthcare.
“We are excited to release our Investor Relations deck and video
presentation on our company website to provide investors in the
public markets with a clear understanding of the business of
Phoenix Life, our mission and our objectives,” said Phoenix Life
Sciences International CEO Martin Tindall. “With all of the
momentum our company is experiencing, we have received continued
interest in better understanding our company and our vision.
Through this presentation, we hope to share more about Phoenix
Life’s global vision of creating natural alternatives to
traditional healthcare and further attract further scientific
partners to join us in our mission.”
Phoenix Life plans to utilize a
vertically integrated operation to produce its medical cannabis
pharmaceutical products and ensure maximum efficacy. The company
aims to partner with the single-payer healthcare systems of both
established and emerging economies to conduct medical studies on
cannabis for diabetes and establish programs for diabetes patients
to receive the company's botanically derived products.
The company is also releasing videos
on its website for the public to learn about its Medical Advisory
Board, its Product Pipeline
and Background
Story. This further expands our News and Media coverage
section of our website. To learn more about what the news is saying
about Phoenix Life Sciences International, please visit the
company’s “In the News” page at: https://plsi.co/news/.
To watch the Investor Relations deck
presentation, please visit http://phxlife.net/PLSI-Deck.
To learn more about Phoenix Life
Sciences International, please visit https://www.phoenixlife.co.
About Phoenix Life Sciences
International Limited
Phoenix Life Sciences International Limited is an adaptive
healthcare solutions company. Our business is to advance research
and integrate programs and manufacturing of products that target
and treat diabetes, pain, cancer, and address psychological,
gastrointestinal, autoimmune, neurological and sleep disorders. We
strive to create partnerships and integrate these programs for
human health into communities worldwide as part of our Global
Health Initiative.
FORWARD-LOOKING
STATEMENTS
Information contained in this press release
regarding Phoenix Life Sciences International, Limited and its
subsidiaries, (the “Companies”) may constitute forward-looking
statements or statements which may be deemed or construed to be
forward-looking statements. The words “plan”, “forecast”,
“anticipates”, “estimate”, “project”, “intend”, “expect”, “should”,
“believe,” and similar expressions are intended to identify
forward-looking statements. These forward-looking statements
involve, and are subject to, known and unknown risks, uncertainties
and other factors which could cause the Company’s actual results,
performance (financial or operating) or achievements to differ from
the future results, performance (financial or operating) or
achievements expressed or implied by such forward-looking
statements. The risks, uncertainties and other factors are more
fully discussed in the Company’s filings with the U.S. Securities
and Exchange Commission. All forward-looking statements
attributable to the Companies herein are expressly qualified in
their entirety by the above-mentioned cautionary statement. The
Companies disclaim any obligation to update forward-looking
statements contained in this press release, except as may be
required by law.
FOOD AND DRUG ADMINISTRATION
(FDA) DISCLOSURE
These statements have not been
evaluated by the FDA and therefore the products sold by Phoenix
Life Sciences International are not available on U.S.
LEGAL DISCLOSURE
Phoenix Life Sciences International
does not sell or distribute any products in the United States that
are in violation of the United States Controlled Substances Act
(US.CSA). This company does not grow, sell, and distribute
cannabis-based products in the United States and is solely involved
with the legal distribution of medical cannabis-based products
within certain international markets outside of the United
States.
Investor
Contact:
Phone: 1.888.717.5655 or
international +1.720.699.7222
E-mail: investor.relations@phoenixlife.co
Media Contact:
Kathryn Reinhardt
CMW Media
Kathryn@cmwmedia.com
619-972-3089
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Sep 2023 to Sep 2024